No abstract

The first trimester fetal ultrasound scan is important to confirm fetal viability, to estimate the gestational age of the fetus, and to detect fetal anomalies early in pregnancy. First trimester ultrasound images have a different appearance than for the second trimester scan, reflecting the different stage of fetal development. There is limited literature on automation of image-based assessment for this earlier trimester, and most of the literature is focused on one specific fetal anatomy. In this paper, we consider automation to support first trimester fetal assessment of multiple fetal anatomies including both visualization and the measurements from a single 3-D ultrasound scan. We present a deep learning and image processing solution i) to perform semantic segmentation of the whole fetus, ii) to estimate plane orientation for standard biometry views, iii) to localize and automatically estimate biometry, and iv) to detect fetal limbs from a 3-D first trimester volume. Computational analysis methods were built using a real-world dataset (n=44 volumes). An evaluation on a further independent clinical dataset (n=21 volumes) showed that the automated methods approached human expert assessment of a 3D volume.

No abstract

The grading of fibrosis in myeloproliferative neoplasms (MPN) is an important component of disease classification, prognostication and monitoring. However, current fibrosis grading systems are only semi-quantitative and fail to fully capture sample heterogeneity. To improve the quantitation of reticulin fibrosis, we developed a machine learning approach using bone marrow trephine (BMT) samples (n = 107) from patients diagnosed with MPN or a reactive marrow. The resulting Continuous Indexing of Fibrosis (CIF) enhances the detection and monitoring of fibrosis within BMTs, and aids MPN subtyping. When combined with megakaryocyte feature analysis, CIF discriminates between the frequently challenging differential diagnosis of essential thrombocythemia (ET) and pre-fibrotic myelofibrosis with high predictive accuracy [area under the curve = 0.94]. CIF also shows promise in the identification of MPN patients at risk of disease progression; analysis of samples from 35 patients diagnosed with ET and enrolled in the Primary Thrombocythemia-1 trial identified features predictive of post-ET myelofibrosis (area under the curve = 0.77). In addition to these clinical applications, automated analysis of fibrosis has clear potential to further refine disease classification boundaries and inform future studies of the micro-environmental factors driving disease initiation and progression in MPN and other stem cell disorders.

No abstract